BioCryst Pharmaceuticals
Price & Volume
Stats
See moreOpen | $7.83 |
Previous Close | $7.82 |
Day Range | $7.75-$7.87 |
52W Range | $6.01-$11.31 |
Market Cap | $1.6B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $557.5M |
Revenue Growth (YoY) | 49.4% |
Gross Profit (12 Mos) | $370.6M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • 22 days ago
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
BioCryst to Present at Upcoming Investor Conference
Yahoo Finance • last month
BioCryst Announces Departure of Dr. Helen Thackray
Yahoo Finance • 2 months ago
BioCryst Pharmaceuticals Inc (BCRX) Q2 2025 Earnings Call Highlights: Record ORLADEYO Revenue ...
About
CEO | Mr. Jon P. Stonehouse |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 580 |
